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WHAT THIS PAPER ADDS
As the population ages and the incidence of diabetes increases, the expected number of patients with critical
limb ischaemia requiring ultra-distal revascularizations will remain high or even increase. This retrospective
study investigated the long-term results of inframalleolar bypass for critical limb ischaemia. The results of this
study demonstrate that inframalleolar bypass yields excellent long-term patency and good limb salvage can be
achieved in both non-diabetic and diabetic patients.
Introduction: As the population ages and the incidence of diabetes increases, the expected number of patients
with critical limb ischaemia (CLI) requiring distal revascularization will remain high or even increase. The aim of
this study was to investigate the long-term results of inframalleolar bypass.
Material and methods: A total of 352 inframalleolar bypasses for CLI performed between 2002 and 2013 were
included. Risk factors were evaluated and patency (both clinical and imaging based), leg salvage, survival, and
amputation free survival (AFS) assessed.
Results: The median follow up was 30 months (mean 42 months, range 1e186 months). The median age of the
study population was 73 years, and 67% of the patients were male. The incidence of diabetes was 69%. In the
majority of cases (82%), the indication for bypass was an ulcer or gangrene, and the remaining 18% of the
patients had rest pain. Primary, assisted primary, and secondary clinical patency was 71.2%, 76.5%, 81.0%, and
59.7%, 69.3%, and 70.7%, and 49.0%, 58.6%, and 68.4% at 1, 5, and 10 years, respectively. The last imaging based
secondary patency at 1, 5, and 10 years was 79.3%, 68.1%, and 62.8%, respectively. The popliteal artery as the
inﬂow artery (n ¼ 194) was associated with superior primary (p ¼ .013), assisted primary (p ¼ .028), and
secondary patency (p ¼ .014) when compared with bypasses originating from the femoral artery (n ¼ 158). The
leg salvage rate at 1, 5, and 10 years was 78.6%, 72.0%, and 67.2%, respectively. Leg salvage was equal in patients
with and without diabetes (p ¼ .460). The respective survival and AFS rates at 1, 5, and 10 years were 70.3%,
37.4%, and 15.9%, and 58.4%, 29.8%, and 12.8%.
Conclusion: Bypass to the foot arteries yielded excellent long-term patency, and good limb salvage can be
achieved in both non-diabetic and diabetic patients.
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INTRODUCTION
Severe peripheral artery disease (PAD) affects the crural
arteries especially in patients with diabetes and those of
advanced age.1 As the population ages and the incidence of
diabetes increases, the expected number of patients with
critical limb ischaemia (CLI) requiring extensive revascular-
ization will remain high or even increase in the future. The
pattern of atherosclerosis is unique in patients with dia-
betes; despite excessive occlusive disease in the crural ar-
teries, the foot arteries are often preserved,2,3 allowing a
pedal bypass in cases of limb threatening ischaemia.
Endovascular revascularization procedures have chal-
lenged bypass surgery as the ﬁrst line treatment for CLI. This
is mainly due to their less invasive nature and subsequent
better short-term survival rates, especially in elderly pa-
tients.4,5 Excellent technical success as well as short- and
mid-term outcomes for endovascular revascularization of
crural arteries have been reported.6 A good technical suc-
cess rate for endovascular revascularization of foot arteries
has also been described.7 However, long-term results for
these procedures are lacking in the literature. On the other
hand, excellent mid- and long-term results of pedal8e10 and
plantar or tarsal artery bypass11 had already been reported
as early as 20 years ago.
Despite rapidly evolving endovascular techniques, there
are still patients with multi-level infrainguinal disease and
long calciﬁed occlusions not amenable to endovascular
procedures. Unsuccessful endovascular revascularization or
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repeated occlusions of crural arteries after endovascular
revascularization are also indications for bypass to the pedal
or plantar arteries. Furthermore, even after successful
endovascular revascularization, legs with a large soft tissue
lesion often tend not to heal. These patients with extensive
tissue loss need rapid and maximum reperfusion of the foot
and might therefore beneﬁt from surgical revascularization
of the foot arteries. Moreover, one special indication for
pedal or plantar bypass is simultaneous microvascular ﬂap
reconstruction.12
At Helsinki University Hospital, the treatment policy for
CLI has traditionally been aggressive. Only patients who are
bedridden, in permanent institutional care, or who suffer
from extensive dementia have been excluded from revas-
cularization. Although endovascular treatment has gained
popularity, the threshold for surgical bypass has been low
for patients with long occlusions, or when endovascular
revascularization fails, or when the leg does not show
healing potential after endovascular treatment. The aim of
the study was to critically evaluate the recent long-term
results of inframalleolar bypass, to compare the results of
these bypasses between diabetics and non-diabetics, and to
assess the role of the inﬂow and outﬂow arteries in these
ultra-distal bypasses.
MATERIAL AND METHODS
A total of 352 patients underwent inframalleolar bypass for
CLI at Helsinki University Hospital between January 2002
and December 2013. These patients were included in this
retrospective study. Demographic data, procedural details,
post-operative outcome, and follow up data were collected
prospectively into the institutional vascular and endovas-
cular database (Husvasc) and scrutinized retrospectively
from the patients’ case records. The demographic data
included age, sex, comorbid conditions (diabetes, coronary
artery disease, hypertension, dyslipidaemia, cerebrovascular
disease, renal insufﬁciency), and smoking history. The pro-
cedural data contained the indications for and details of the
bypass, such as the inﬂow and outﬂow vessels as well as
graft materials. The post-operative data included compli-
cations and outcome at discharge. The follow up data
comprised limb status, graft patency, and the dates of any
graft revisions (surgical or endovascular) or graft occlusion
as well as the dates of possible major amputation and/or
death. The dates of death and amputations were cross-
checked and, if missing, retrieved from the Population
Register Centre, and the amputation registry, respectively.
Pre-operative assessments and details of the procedure
Only bypasses to the arteries below malleolar level (the
dorsalis pedis, tarsal, or plantar arteries) were included.
Tarsal artery bypasses were analysed in same category as
pedal bypasses. The suitability of the inﬂow and outﬂow
arterial anatomy for bypass was evaluated by means of
magnetic resonance angiography (MRA) or conventional
digital subtraction angiography (DSA). If there was no visible
recipient artery on the MRA or DSA, duplex ultrasound
(DUS) was performed to ﬁnd a potentially open recipient
artery in the foot. During the earlier years of the study, a
blind exploration of a dorsalis pedis or plantar artery not
seen on angiography but thought to be patent on the basis
of an audible Doppler signal was occasionally performed.
Autologous vein grafts were used whenever possible. The
size and quality of the vein material was evaluated pre-
operatively with ultrasonography, and the best available
vein graft was preferred. Thus, in the absence of the ipsi-
lateral great saphenous vein (GSV), the contralateral GSV
was used as a conduit unless the donor limb was obviously
ischaemic. Arm veins or the small saphenous vein were
used if a usable GSV (ipsilateral or contralateral) was ab-
sent. If a single segment vein graft was not available, a
spliced vein graft with two or more segments was applied.
In most cases, a non-reversed, translocated vein graft was
used, but the operating surgeon eventually decided, case by
case, whether the vein graft was to be used in a reversed or
non-reversed conﬁguration. If a spliced vein graft was
applied, reversed or non-reversed vein segments were
employed to minimise the size mismatch of the vein to vein
and the conduit to artery anastomoses. A prosthetic graft
with a vein cuff was used in four cases in the absence of a
usable vein graft.
Transit time ﬂow measurement was carried out to ensure
adequate graft ﬂow (mL/min) at the end of the procedure.
If the graft ﬂow was considered compromised, intra-
operative duplex scanning was performed to exclude graft
segments of inappropriate quality and technical defects in
anastomoses. Angioscopy or intra-operative angiography
was used selectively, not routinely. Intra-operative heparin
was administered to all patients according to their weight,
and the adequacy of the heparinization was controlled us-
ing activated clotting time (ACT) assessment. All patients
received weight adjusted doses of low molecular-weight
heparin twice a day post-operatively until discharge and
acetylsalicylic acid (ASA) 100 mg per day indeﬁnitely if there
were no contraindications (aspirin allergy). Some patients
received clopidogrel instead of aspirin (aspirin allergy, pre-
vious coronary balloon angioplasty, etc.). Warfarin was not
used routinely unless there was a clear indication for it
(atrial ﬁbrillation, thrombophilia, etc.).
The standard surveillance protocol included follow up
visits at 1, 6, 12, and 24 months post-operatively. Patients
with open wounds or with a graft revision or at risk graft
were followed up more frequently. Each follow up visit
included an inspection of limb status as well as pulse
palpation and the measurement of ankle brachial indices
and toe pressures. Duplex scanning of the entire graft and
both anastomoses was performed and, if a signiﬁcant ste-
nosis (velocity ratio [v1/v2] 3) was suspected, angiography
and balloon angioplasty (percutaneous transluminal angio-
plasty, (PTA)) were scheduled. After a surgical revision or
graft PTA, the surveillance protocol was repeated from the
beginning. In September 2014, all patients who were alive
without an amputation were invited to a late follow up
where duplex scanning of the graft was performed to verify
graft patency. The patient records of those who underwent
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a major amputation of the index limb during the study
period were checked to evaluate whether the graft was
patent or occluded at the time of the amputation. For those
patients who died during the study period, the graft
patency was assessed using last imaging (DUS, MRA, or
DSA) based patency. Clinical patency (last date when graft
pulse was detected) was also assessed, because in pedal
and plantar bypasses the graft lies superﬁcially and there-
fore the graft pulse can easily be palpated.
Diabetes was deﬁned as hyperglycaemia requiring a
special diet, oral medication, or insulin treatment. Coronary
artery disease (CAD) was deﬁned as a previously docu-
mented myocardial infarction and/or ongoing angina pec-
toris, or previous coronary bypass surgery or a
percutaneous coronary intervention. Cerebrovascular dis-
ease was deﬁned as a previous stroke or transient ischemic
attack (TIA). Renal dysfunction was determined if the serum
creatinine level was >120 mmol/L.
Statistical analysis
Continuous variables are expressed as median, SD, and
range and the prevalence of risk factors as proportions.
Survival, leg salvage, and amputation free survival rates
with mean standard errors (SE) were calculated with the
KaplaneMeyer method. The ManteleCox log rank test was
used to compare survival curves. Statistical analysis was
performed using SPSS 19.0 statistical software (IBM SPSS
Inc., Chicago, IL, USA). The study protocol was approved by
the Institutional Review Board of Helsinki University Central
Hospital (Department of Surgery).
RESULTS
The median follow up was 30 months (mean 42 months,
range 1e186 months). The median age was 73 years, and
67% of the patients were male. The incidence of diabetes
was 69%, and 68% of the patients had coronary artery
disease. The incidence of renal insufﬁciency was 26%. In the
majority of cases (82%), the indication for bypass surgery
was an ulcer or gangrene (Fontaine class IV), but 18% of the
patients had rest pain alone (Fontaine class III) (Table 1). All
except four bypasses (99%) were performed using a vein
graft. All four prosthetic bypasses occluded within 4
months. The majority of the vein grafts (n ¼ 241) were
single segment GSV grafts. There were 24 alternative
autologous vein grafts (small saphenous vein and cephalic
vein), and 82 bypasses were performed using spliced vein
grafts (Table 2).
Seventy-nine (22.4%) patients had undergone previous
endovascular treatment to the index limb before infra-
malleolar bypass.
At the end of the study period, 104 patients were alive
and 83 of them had not undergone amputation. Of these
patients, 42 had attended a recent follow up visit with
routine duplex scan and the patency of the grafts was
documented in their records. The remaining 41 patients
with uncertain graft patency were re-checked. Twenty-ﬁve
patients attended a late follow up visit and graft patency
was assessed with DUS. Sixteen patients were not able to
attend the late visit. Of these, ﬁve patients had undergone
MRA showing a patent graft. The remaining 11 patients
were visited by a vascular nurse and the patency of the
graft was conﬁrmed by portable ultrasound (Fig. 1).
Clinical primary, assisted primary, and secondary patency
was 71.2%, 76.5%, and 81.0%, 59.7%, 69.3%, and 70.7%,
and 49.0%, 58.6%, and 68.4% at 1, 5, and 10 years,
respectively. Imaging based secondary patency was 79.3%,
68.1%, and 62.8% at 1, 5, and 10 years, respectively (Fig.
2AeD, Table 3). The popliteal artery as the inﬂow artery
(n ¼ 194) was associated with superior primary (p ¼ .013),
assisted primary (p ¼ .028), and secondary patency (p ¼
.014) compared with bypasses originating from the femoral
artery (n ¼ 158) (Fig. 3AeC). Similarly, leg salvage at 1, 5,
and 10 years was better in bypasses originating from the
popliteal artery (81.1% vs. 75.1%, 79.2% vs. 64.2%, and
71.8% vs. 64.2%, respectively; p ¼ .042). The recipient ar-
tery did not affect patency; bypasses to dorsalis pedis artery
Table 1. Demographic data of the study population.
Demographics n %
Age, mean (median) 37e99 (73)
Male sex 235 67
Hypertension 285 81
Dyslipidaemia 267 76
CAD 238 68
DM 240 69
Renal insufﬁciencya 90 26
Cerebrovascular disease 84 24
Current smoking 145 41
COPD 59 17
Indication
Rest pain 64 18
Ulcer 215 61
Gangrene 73 21
CAD ¼ coronary artery disease; COPD ¼ chronic obstructive
pulmonary disease; DM ¼ diabetes mellitus.
a Serum creatinine >120 mmol/L.
Table 2. Operative details of the study population.
Operative details n %
Primary/redo 286/66 81/19
Elective/urgent 161/191 46/54
Inﬂow
Femoral artery 158 45
Popliteal artery 194 55
Outﬂow
DPA 281 80
Plantaris 71 20
Graft material
Autologous vein
1 piece 266 76
GSV 241
SSV 4
Arm vein (cephalica) 20
Spliced vein 82 23
Prosthesis (PTFE) 4 1
DPA ¼ dorsalis pedis artery; GSV ¼ great saphenous vein; SSV ¼
small saphenous vein; PTFE ¼ polytetraﬂuoroethylene.
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(n ¼ 281) had the same patency as bypasses to the plantar
artery (n ¼ 71) (p ¼ .920). The leg salvage rate of the
overall study population at 1, 5, and 10 years was 78.6%,
72.0%, and 67.2%, respectively. Leg salvage was equal in
patients with and without diabetes (p ¼ .460; Fig. 4). The
respective survival and amputation free survival (AFS) rates
at 1, 5 and 10 years were 70.3%, 37.4%, and 15.9%, and
58.4%, 29.8%, and 12.8% (Table 3).
There was no differences between primary (81%) and
redo bypasses (19%) regarding primary patency (p ¼ .611),
assisted primary patency (p ¼ .344), secondary patency
(0.690), leg salvage (p ¼ .510) or survival (p ¼ .120). Pre-
vious endovascular treatment did not have impact on
patency (primary patency p ¼ .396; assisted primary
patency p ¼ .491; secondary patency p ¼ .132), or survival
(p ¼ .387). However, there was a trend towards better leg
salvage in patients without previous endovascular treat-
ment (at 1 year 80.4% vs. 69.9%, at 5 years 72% vs. 61.4%,
at 10 years 64.8 vs. 53.7%), but the difference was not
statistically signiﬁcant (p ¼ .069).
The peri-operative (30 day) mortality rate was 6.5%. Early
(30 day) graft failure rate was 4.3%. Cardiac complication
(post-operative myocardial infarction or unstable angina)
occurred in 16 (4.5%) patients. Eight patients (2.3%) had
post-operative pneumonia and one patient (0.2%) had post-
operative sepsis. Post-operative renal failure (serum creat-
inine rise >50% from the pre-operative level) occurred in
two patients (0.6%).
DISCUSSION
This study demonstrates that good long-term patency and
leg salvage can be achieved with distal bypasses to the foot
arteries. The patency was not inferior in diabetic patients
compared with non-diabetics. Furthermore, it was found
that the patency was signiﬁcantly higher if the inﬂow was
taken from the popliteal artery as opposed to groin level.
The limitations of this study are the lack of a control
group as well as its retrospective nature. Other ﬂaws are
the lack of data regarding wound healing, relief of rest pain
and functional outcome (return to mobility, etc.). The
standard duplex surveillance lasted only 2 years. However,
those patients who were alive with a leg were invited to a
late follow up visit and the graft patency was assessed with
duplex scanning. For those patients who had died during
the study period, both last imaging based and clinical
patency were assessed. Comprehensive data on amputa-
tions and deaths were also available as they were extracted
from national registries. As regards these outcome mea-
sures, no patients were lost to follow up.
The results in terms of patency and leg salvage are similar
to those published by Pomposelli et al.,9 whereas survival in
the present series was less good. A probable reason for the
inferior survival is the higher median age of the patients
and the high incidence of coronary artery disease in this
study. This reﬂects the fact that there were two types of
patients undergoing inframalleolar bypass, younger di-
abetics with distal PAD and elderly patients with multi-level
PAD. The latter group has several comorbid conditions and
can be considered as high risk.
One interesting ﬁnding was the patencyeleg salvage gap.
At 1 year, the secondary patency was better than the leg
salvage rate, indicating that there were amputations per-
formed with a patent graft. This phenomenon has been
documented in other series mostly including diabetic pa-
tients. In the series of Carsten et al.,13 persistent infection
despite a patent bypass was the reason for early amputa-
tions in 4.4% of the patients. Similarly, Virkkunen et al.14
reported that, after bypass for CLI, signiﬁcantly more dia-
betic than non-diabetic patients underwent an amputation
despite successful revascularization. On the other hand, at 5
and 10 years, the leg salvage was better than secondary
patency, indicating that once the ischaemic lesion has
healed, later graft occlusion does not necessarily lead to
limb loss. A similar ﬁnding has been published by others.15
In this series, the patency and leg salvage rate of by-
passes originating from the popliteal artery was superior to
those originating from the femoral artery. The leg salvage
rate of these bypasses remained over 70% at 10 years. The
patients undergoing a femoral to pedal/plantar bypass are
probably those suffering from the most serious form of
PAD, whereas those undergoing a popliteo-pedal/plantar
bypass have more restricted PAD. A shorter bypass en-
ables the use of an optimal size and quality of vein graft.
Moreover, the incidence of post-operative wound infections
is probably lower when a groin incision can be avoided. In
contrast to this ﬁnding, Brochado Neto et al.15 found no
signiﬁcant difference in the patency of short versus long
grafts in their series of inframalleolar bypasses.
In the current study, the cumulative leg salvage rate in
diabetic patients was equal to that of non-diabetic patients.
Similarly, there are studies suggesting that diabetics with CLI
could achieve an equal outcome to non-diabetics after
infrainguinal bypass with an aggressive, multidisciplinary
approach, including experience in extremely distal revas-
cularization as well as aggressive treatment of infections,
frequent debridement, biomechanical off-loading, blood
All n = 352
Dead n = 248 Alive n = 104
Amputated n = 21
Alive with leg n = 
83
Gra? patency
documented
recently n = 42
Gra? patency
unclear n = 41 
Invited to 
follow up visit 
n = 41
A?ended follow up 
visit, DUS 
performed n = 25
Patency confirmed
with MRA n = 5
Home visit and 
DUS n = 11
Figure 1. Flowchart of patients undergoing inframalleolar bypass.
DUS ¼ duplex ultrasound; MRA ¼ magnetic resonance
angiography.
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glucose control, and treatment of comorbidities.10,16,17
Actually, in the present study, there even seems to be a
slight trend (though not statistically signiﬁcant) towards
better leg salvage in diabetic versus non-diabetic patients. A
probable reason for this ﬁnding is that, because of the more
distal location of PAD, diabetics undergo more popliteo-
pedal/plantar bypasses, and the leg salvage rate for these
bypasses was superior.
Inframalleolar bypass is often the last option for limb
salvage. Therefore, it is of paramount importance to focus
on the technical aspects, such as the ultrasound assisted
vein graft and distal anastomotic site marking to optimize
incisions in order to avoid wound problems. With a dedi-
cated vein mapping policy it was possible to ﬁnd an
autologous graft in 348 out of 352 (99%) patients. A
meticulous surgical technique is also necessary. We use
translocated, non-reversed vein grafts for several reasons.
The in situ technique limits the possibility to choose the
best segment of the vein for the bypass and for a common
femoral artery anastomosis there might be tension on the
proximal segment of the graft. The wound complication risk
may be increased at the pedal anastomosis due to the need
for parallel skin incisions. Moreover, translocated grafts can
Figure 2. Cumulative (A) primary, (B) assisted primary, (C) secondary patency, and (D) last imaging based secondary patency of infra-
malleolar bypasses.
Table 3. Outcome with standard error of all pedal bypasses.
1 year (%) 5 year (%) 10 year (%)
Primary patency 71.2  2.6 59.7  3.2 49.0  5.0
Assisted
primary patency
76.5  2.4 69.3  2.9 58.6  4.9
Secondary patency 81.1  2.2 70.7  3.1 68.4  3.8
Secondary patency
(last imaging based)
79.3  2.4 68.1  3.5 62.8  3.8
Leg salvage 78.6  2.6 72.0  2.8 67.2  4.0
Survival 70.3  2.4 37.4  2.8 15.9  2.5
Amputation
free survival
58.4  2.6 29.8  2.6 12.8  2.2
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be tunnelled deeply to avoid problems in case of wound
infection and/or dehiscence. It is strongly believed that
duplex surveillance of these grafts is crucial for the timely
detection and treatment of vein graft stenosis as failed
grafts have poor long-term patency and only moderate limb
salvage rates.18 Endovascular techniques and inframalleolar
bypass are not competing but rather complementary op-
tions for limb salvage. As long as there are no data on the
long-term results of endovascular revascularization of foot
arteries, inframalleolar bypass is a durable option if a good
quality vein graft is available and the patient has a good life
expectancy. Inframalleolar bypass should also be offered
after failed or inadequate endovascular revascularization;
there are data suggesting that a prior endovascular inter-
vention to crural occlusions does not have a negative
impact on the outcome of a subsequent pedal bypass as
long as destruction of the target vessel is avoided and the
bypass is performed without excessive delay.19 Similarly,
results of this study demonstrated that previous endovas-
cular treatment did not affect the outcome of subsequent
Figure 3. Cumulative (A) primary, (B) assisted primary, and (C) secondary patency of bypasses originating from popliteal artery versus
bypasses originating from femoral artery.
Figure 4. Cumulative leg salvage of diabetic versus non-diabetic
patients. DM ¼ diabetes mellitus.
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bypass. Furthermore, there was no difference in outcome
between primary and redo bypasses. Therefore an active
revascularization policy also seems to be worthwhile in
patients with a history of previous bypass if there is a good
quality vein graft available.
Only one randomized study on the treatment of CLI
comparing surgical and endovascular treatment has been
published.20 Differences between the treatment methods
were not found. There was a trend towards a better
outcome in the surgical group when the patient’s life ex-
pectancy was more than 2 years.21 In a propensity score
analysis from this institution,22 with 1023 patients treated
for infrapopliteal CLI with either endovascular or surgical
revascularization procedures to the crural or pedal arteries,
PTA and bypass surgery achieved similar 5 year leg salvage
(75.3% vs. 76.0%) and amputation free survival (37.7% vs.
37.3%) rates, whereas freedom from surgical revasculari-
zation was higher after bypass surgery (94.3% vs. 86.2%, p
< .001). The study included all infrapopliteal re-
vascularizations, not only those with a patent outﬂow vessel
at the inframalleolar level. In patients who undergo infra-
malleolar bypass, treatment by endovascular means is often
difﬁcult due to long occlusions of the crural arteries. How-
ever, it would be interesting to perform a similar propensity
score analysis with these patients.
CONCLUSION
Bypass to the inframalleolar arteries yields excellent long-
term patency, and good limb salvage can be achieved in
both non-diabetic and diabetic patients.
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Tracheo-innominate Artery Fistula
L. Machado *, A. Mansilha
São João Hospital Center, Serviço de Angiologia e Cirurgia Vascular, Porto, Portugal
The authors present a case of a 76-year-old man seen at the Emergency Department with a self-limiting bleed from a
tracheostomy, 2 weeks after open tracheostomy. A subsequent computed tomography scan revealed an innominate artery
pseudoaneurysm in contact with the anterior aspect of the trachea. The patient underwent surgical correction of the
pseudoaneurysm with a bifurcated bypass from the ascending aorta to the right common carotid and right subclavian ar-
teries. Fistula formation between the trachea and the innominate artery is a rare complication of tracheostomy, almost
always fatal without surgical treatment, and such herald bleeds are an important warning sign.
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